HIMS broadens beyond telehealth, adding labs, new hormone programs and global expansion as it builds a personalized care ...

Findings seen over three months in men with low-grade prostate cancer, hypogonadism treated with radical prostatectomy.

The body's hormones have a subtle and powerful influence on nearly all functions. As they start to decline, particularly with ...

The DOJ recently reached out to a lawyer representing a client suing CHOP to ask if he would be a witness in its ...

Confronted with Trump Administration threats to gender-affirming care for young transgender people, American families are ...

When one thinks about male infertility, the most common things considered are age, stress, problems with erection, sperm ...

Keke Palmer is opening up about a health battle that left her dealing with what she describes as “unbearable” and “crippling” ...

The tapes didn't just expose police bias — they birthed a media practice of naming the slur indirectly by calling it "the ...

Stigma is fading and new laws are passing that will help increase access to menopause treatment. When Jacqueline Perez started experiencing symptoms of menopause in her early 50s, the brain fog was so ...

As many as 50 million Americans live with an autoimmune disease, a broad category of disorders in which the immune system ...

Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research May 19, 2026 4:00 PM ...

A preclinical study from Fudan University demonstrates that fexaramine, a gut-restricted FXR agonist, addresses both metabolic and reproductive complications in PCOS mouse models. Researchers at Fudan ...